ASP Isotopes (ASPI) Competitors

Braskem (NYSE:BAK) and ASP Isotopes (NASDAQ:ASPI) are both small-cap energy companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.

Do institutionals and insiders believe in BAK or ASPI?

16.8% of ASP Isotopes shares are held by institutional investors. 0.0% of Braskem shares are held by company insiders. Comparatively, 21.4% of ASP Isotopes shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media refer more to BAK or ASPI?

In the previous week, Braskem and Braskem both had 3 articles in the media. ASP Isotopes' average media sentiment score of 0.90 beat Braskem's score of 0.22 indicating that ASP Isotopes is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Braskem	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
ASP Isotopes	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer BAK or ASPI?

Braskem received 58 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 53.28% of users gave Braskem an outperform vote.

Company	Underperform	Outperform
Braskem	Outperform Votes 65 53.28%	Underperform Votes 57 46.72%
ASP Isotopes	Outperform Votes 7 100.00%	Underperform Votes No Votes

Which has better valuation & earnings, BAK or ASPI?

ASP Isotopes has lower revenue, but higher earnings than Braskem. ASP Isotopes is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Braskem	$77.41B	0.02	-$917.17M	-$5.17	-0.68
ASP Isotopes	$4.14M	113.56	-$16.29M	-$0.61	-10.70

Do analysts recommend BAK or ASPI?

Braskem presently has a consensus target price of $9.75, indicating a potential upside of 179.37%. ASP Isotopes has a consensus target price of $4.50, indicating a potential downside of 31.09%. Given Braskem's higher probable upside, analysts plainly believe Braskem is more favorable than ASP Isotopes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Braskem	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
ASP Isotopes	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is BAK or ASPI more profitable?

Braskem has a net margin of -9.88% compared to ASP Isotopes' net margin of -807.39%. ASP Isotopes' return on equity of -123.83% beat Braskem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Braskem	-9.88%	-439.59%	-4.12%
ASP Isotopes	-807.39%	-123.83%	-51.58%

Which has more risk and volatility, BAK or ASPI?

Braskem has a beta of 1.8, suggesting that its stock price is 80% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.44, suggesting that its stock price is 244% more volatile than the S&P 500.

Summary

ASP Isotopes beats Braskem on 11 of the 17 factors compared between the two stocks.